Top Markets
#1 MowCat MowCat +368.53%
#2 龙虾 (Lobster) 龙虾 (Lobster) +73.40%
#3 SODAX SODAX +51.18%
#4 Cortex Cortex +31.85%
#5 DexNet DexNet +23.19%
#6 BNB Attestation Service BNB Attestation Service +18.76%
#7 Magma Finance Magma Finance +18.39%
#8 Akedo Akedo +16.65%
#9 OpenEden OpenEden +15.79%
#10 MANTRA MANTRA +14.99%
Coin of the day
MowCat MowCat
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
China National Accord Medicines Corporation Ltd. China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd.

000028
Kedudukan dalam Saham #7537
China National Accord Medicines Corporation Ltd. primarily focuses on the... China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.
Harga Saham
$2.90
Modal Pasaran
$1.55B
Perubahan (1 hari)
0.15%
Perubahan (1 tahun)
-11.06%
Negara
CN
Perdagangan China National Accord Medicines Corporation Ltd. (000028)

Kategori

Healthcare
Nisbah P/E bagi China National Accord Medicines Corporation Ltd. (000028)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini China National Accord Medicines Corporation Ltd., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi China National Accord Medicines Corporation Ltd. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 23.15 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 32.35 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 -338.64 -
AU
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.